A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Northwestern Medicine is an integrated healthcare system that brings together physicians and researchers from award-winning facilities in the Chicago area. Each of the Northwestern Medicine hospitals has a unique story, but the system shares the same vision. Northwestern Medicine is committed to superior quality, academic excellence, scientific discovery and patient safety.
Chicago, Illinois Clinical Trial Location
Northwestern Medical Center
446 E Ontario St,
Chicago, IL 60611